Concepedia

Meseret Tamirat

MT

Statistics

Publications

3

Citations

61

H-Index

3

Active since

2021

Affiliations

EsSALUD(Current)

Médecins Sans Frontières

Partners In Health

Harvard University

Harvard Global Health Institute

Meseret Tamirat is an author at EsSALUD specializing in tuberculosis drug resistance, tuberculosis pharmacotherapy, and six-month treatment regimens.

Publications per year

2021–2023

3

Publications

3

Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial

Lorenzo Guglielmetti, Elisa Ardizzoni, Marc Atger et al. · Trials · 2021 · 32 citations · Full text

, , +15

All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings

Palwasha Khan, Molly F. Franke, Catherine Hewison et al. · European Respiratory Journal · 2021 · 16 citations

, , +10

Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial

Shrikant Patil, Meseret Tamirat, K S Khazhidinov et al. · Trials · 2023 · 13 citations · Full text

, , +13

1–3 of 3